80.3 F
Thursday, September 23, 2021

News: Pure Transplant Solutions, LLC and University Hospital Basel Announce Research Collaboration | CitizenWire

Developing New Diagnostics for Donor Specific Antibodies (DSA) in Transplant Rejection AUSTIN, Texas /CitizenWire/ -- Pure Transplant Solutions, LLC (PTS), a collaboration driven biotechnology company focused on the development of human leukocyte antigen (HLA)-based diagnostics and therapeutics within the field of transplantation, is proud to announce that it has entered into a research collaboration with…

News: Microcide Announces Launch of Speed-breaker for Fast Moving COVID-19 Infections for Health Care...

STERLING HEIGHTS, Mich. /CitizenWire/ -- Microcide® Inc. a leading Michigan based biotechnology company, today announced the test results of its COVID-19 faster virus killing range of products, PRO-SAN® Cleaner sanitizer, SILKY-SOFT® hand sanitizer, and DENTORAL® mouthwash. Microcide®'s EPA registered PRO-SAN® L RTU sanitizer spray product has been found to kill 99.999% SARS-CoV-2 (COVID-19) within 30…

News: Synthetic Biology for Tennessee Schools: BioBuilder Partners with Niswonger Foundation on $8.8M Federal...

CAMBRIDGE, Mass. /CitizenWire/ -- The BioBuilder Educational Foundation announced that they are to partner with the Niswonger Foundation on their award of an "Education Innovation and Research" (EIR) Grant from the U.S. Department of Education that will focus on educational opportunities in Science, Technology, Engineering and Mathematics (STEM). BioBuilder will provide teacher professional development in…

China Is Using Human Testing To Develop ‘Biologically Enhanced’ Soldiers, Top Intelligence Official Says

China has conducted human testing on members of its military in an effort to develop “biologically enhanced” soldiers, Director of National Intelligence John Ratcliffe wrote in a Wall Street Journal op-ed Thursday. .@DNI_Ratcliffe outlines why China is a “once-in-a-generation challenge” and the greatest national security threat America faces in a @WSJ op-ed: https://t.co/Qk0UPgwtQG — Office…

News: Zeteo Biomedical to Collaborate with Iowa State University Nanovaccine Institute to Study a...

A nasal vaccine that can be self-administered is crucial to protect global populations against pandemic virus threats AUSTIN, Texas /CitizenWire/ -- Zeteo Biomedical LLC, Inc., a privately held medical device company, has partnered with the Nanovaccine Institute at Iowa State University to study a nasal SARS-CoV-2 vaccine. Zeteo will provide nasal delivery device technology and…

CitizenWire: Progenabiome Shares New Data on Fecal Transplant, Sars-Cov-2 at ACG 2020

VENTURA, Calif. /CitizenWire/ -- The American College of Gastroenterology (ACG) named Progenabiome "Outstanding Poster Presenter" for its poster: "Successful Bacterial Engraftment Identified by Next Generation Sequencing Following Fecal Microbiota Transplantation for Clostridioides difficile Infection," which will be presented virtually at the ACG Annual Scientific Meeting this week. From close to 2900 posters, only roughly 10%…

NEWS: Pure Protein, LLC to Exhibit and Preview New Website at the American Society...

OKLAHOMA CITY, Okla., Oct 15, 2020 (SEND2PRESS NEWSWIRE) -- Pure Protein, LLC (Pure Protein) an HLA company that has developed comprehensive analytical capabilities in the field of human leukocyte antigen (HLA) immunology and an approach to produce soluble forms of the HLA molecule (sHLA), announced today that it will be an exhibitor at the ASHI…

NEWS: Zeblok Computational Announces Partnership with Laufer Center and CEWIT – COVID-19 Drug Discovery

STONY BROOK, N.Y., Jul 20, 2020 (SEND2PRESS NEWSWIRE) -- Zeblok Computational is contributing to the efforts of two groups of researchers at The Laufer Center for Physical and Quantitative Biology, for COVID-19 drug discovery by providing Zeblok's secure, scalable Supercomputing-as-a-Service platform, employing 128 GPUs from the CEWIT SMART GPU Cluster. The Laufer Center simulations focus…

NEWS: ROKiT Pharma’s Preclinical Studies Showing Tremendous Promise for Naturally Derived Cancer Drug, ROK-001...

LOS ANGELES, Calif., Apr 02, 2020 (SEND2PRESS NEWSWIRE) -- ROKiT Pharma, Inc., a public-benefit corporation dedicated to putting patients first, announced today it is rapidly progressing through final preclinical studies and moving forward with preparation for the initiation of a Phase 1b/2 clinical trial of ROK-001, a potentially low toxicity cancer drug derived from natural…

NEWS: Lyme Disease Biobank Expands Into San Diego

SAN DIEGO, Calif., Mar 06, 2020 (SEND2PRESS NEWSWIRE) -- Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the U.S., announces the opening of the San Diego collection site of the Bay Area Lyme Foundation's Lyme Disease Biobank, which is the first program to provide researchers with blood and urine samples from…

Recent Posts

USD - United States Dollar